Processes and Supercritical Fluids

Supercritical extraction

Supercritical fractionation

Particle generation, crystallization, encapsulation

Impregnation (polymeric matrices and implants, silicas, ...)

suite...

Processes and Supercritical Fluids Team
About

Supercritical (FSC) or subcritical fluids have specific properties which are exploited in a large number of applications at both laboratory and industrial scales. Their use represents an alternative to the use of organic solvents presenting pollution, toxicity and/or safety problems.

The “Supercritical Processes & Fluids” team has particular scientific and technological expertise enabling the design, operation and optimization of processes using supercritical CO2.
For better control of these processes, a multi-scale approach is favored. The team particularly studies the properties of supercritical fluids, phase equilibria, interface phenomena and transfers in pressurized media. Particular attention is also paid to the behavior of materials, both of synthetic and biological origin, in contact with supercritical CO2.
Modeling tools developed within the team make it possible to understand more specifically the transfer kinetics (flows, dispersion phenomena, mixing) and the thermodynamics of these pressurized environments. 

The team has strong activity focused on the following applications:
- Supercritical extraction, supercritical fractionation and shaping of plant origin products
- Development of sustained drug delivery systems (crystallization of active ingredients, encapsulation, impregnation, etc.)
- Supercritical sterilization of medical devices and health products
- Supercritical decellularization of grafts

Industrial partners (period 2020-2024):

BiotechOne ; Cousin Surgery ; Lattice Medical ; French Red ; Solvay ; Symrise ; THEA ; Total Energies

Team leader

x >

Annuaire personnel permanent

x >

Doctorants, Post-Doctorants et CDD

x >

Equipement

- Autoclaves d'extraction, de cristallisation et d'imprégnation - de quelques mL à plusieurs litres.
- Montage expérimental de cristallisation ou d'encapsulation en milieu supercritique.
- Pilote de fractionnement supercritique
- Autoclave à fenêtre
- Cellules Haute Pression de mesures d'équilibres de phases résistant jusqu'à 700 bar. 

Dernières publications de l'équipe

  • Aymeric Fabien, Guillaume Lefebvre, Elisabeth Badens, Brice Calvignac, Damien Chaudanson, et al.. Contact angle of ethanol, water, and their mixtures on stainless steel surfaces in dense carbon dioxide. Journal of Colloid and Interface Science, 2024, 655, pp.535-545. ⟨10.1016/j.jcis.2023.10.163⟩. ⟨hal-04316090⟩ Plus de détails...
  • Vénicia Numa, Christelle Crampon, Arnaud Bellon, Adil Mouahid, Elisabeth Badens. Valorization of food side streams by supercritical fluid extraction of compounds of interest from apple pomace. Journal of Supercritical Fluids, 2023, 202, pp.106056. ⟨10.1016/j.supflu.2023.106056⟩. ⟨hal-04294235⟩ Plus de détails...
  • Vénicia Numa, Christelle Crampon, Arnaud Bellon, Adil Mouahid, Elisabeth Badens. Valorization of food side streams by supercritical fluid extraction of compounds of interest from apple pomace. Journal of Supercritical Fluids, 2023, 202, pp.106056. ⟨10.1016/j.supflu.2023.106056⟩. ⟨hal-04543465⟩ Plus de détails...
  • Alejandra Gutiérez Márquez, Gatien Fleury, Alexandra Dimitriades-Lemaire, Pablo Alvarez, Gregory Santander, et al.. Potential of the worldwide-cultivated cyanobacterium Arthrospira platensis for CO2 mitigation: Impacts of photoperiod lengths and abiotic parameters on yield and efficiency. Bioresource Technology Reports, 2023, 22, pp.101439. ⟨10.1016/j.biteb.2023.101439⟩. ⟨hal-04702177⟩ Plus de détails...
  • Christelle Crampon, Thibaud Detoisien, Lama Itani, Fréderic Nicolas, Emmanuelle Myotte, et al.. Novel crystal morphology for sodium bicarbonate obtained by using the supercritical anti-solvent process. Powder Technology, 2023, 418, pp.118313. ⟨10.1016/j.powtec.2023.118313⟩. ⟨hal-04546398⟩ Plus de détails...
x >

Rencontres scientifiques

Soutenances de thèses et HDR

25 novembre 2024 - Design and optimization of supercritical treatment processes for interventional cardiology medical devices / Zohra Laggoune PhD Defense
Doctorante : Zohra Laggoune

Date : 25 novembre à 14h00, Cerege amphi Technopôle de l'Arbois-Méditerranée

Abstract: Atherosclerosis, a leading cardiovascular condition, involves arterial narrowing due to fatty deposits, impeding blood flow. Angioplasty, using stents or balloons, is a minimally invasive treatment for atherosclerosis. Recent advances have led to the development of active stents and balloons, which release antiproliferative agents (e.g., sirolimus) via a polymeric coating to prevent restenosis and promote arterial healing. Conventionally, these devices are manufactured using organic solvents, and may then contain harmful residues posing environmental and health concerns.
This thesis, conducted in collaboration with AlchiMedics, investigates supercritical CO2 technology as an eco-friendly alternative for manufacturing active coronary medical devices. The study first focuses on the behavior of the polymers that compose them in a supercritical CO2 environment. A Fourier Transformed InfraRed microscope coupled with a high-pressure cell was used to measure CO2 sorption in the polymers and their swelling. Additionally, a high-pressure visualization cell was used to assess the physical state of the polymers when exposed to supercritical CO2. Furthermore, the solubility in supercritical CO2 of sirolimus, the main active ingredient involved in this thesis, was determined using a static gravimetric method, followed by data modeling.
Based on this fundamental knowledge, supercritical CO2 was applied to extract residual solvent from pre-dried active stents (HT Supreme®). Semi-continuous mode extraction at 8 MPa, 308.15 K for 0.5 h resulted in an extraction efficiency of 91.80 % while minimizing polymer detachment and ensuring satisfactory in-vitro sirolimus release.
This study also explores supercritical impregnation of sirolimus to develop active balloons and stents, targeting a drug loading of 1.2 µg.mm-2 for both devices. Balloon impregnation was performed in batch mode based on a Design of Experiments. Operating conditions of 18 MPa, 323.15 K for a duration of 18 h were identified to maximize the drug loading to 0.68 µg.mm-2, while achieving positive ex-vivo results. In contrast, impregnations of two types of commercial stents (AMS® and HT Supreme®) resulted in low drug loadings and detachment of polymeric coatings. The development of the Fast Impregnation process (FIP), significantly improved drug loadings from 0.035 to 1.11 µg.mm-2 for AMS®, and from 0.015 to 7.3 µg.mm-2 for HT Supreme®. This process also preserved the integrity of polymer coatings under conditions set at 12.5 MPa and 308.15 K for AMS®, and at 25 MPa and 313.15 K for HT Supreme®.

Keywords: Atherosclerosis, active coronary stent, active coronary balloon, polymers, supercritical CO2, impregnation, extraction, sterilization

Jury :
Pr. Albertina CABAÑAS - Complutense University of Madrid - Reviewer
Pr. Iolanda DE MARCO - University of Salerno -  Reviewer
Dr. Thierry TASSAING - University of Bordeaux- Examiner and president of the jury
Pr. Loïc MACÉ - Aix Marseille University - Examiner
Pr. Elisabeth BADENS -  Aix Marseille University - Thesis director 
Dr. Yasmine MASMOUDI - Aix Marseille University - Thesis co-director
Dr. Christophe BUREAU - AlchiMedics - Thesis co-director and guest member 
24 septembre 2024 - Supercritical technology applied to the development of innovative intravitreal sustained-release drug delivery systems / Matthieu Schneider PhD defense
Doctorant : Matthieu SCHNEIDER

Date : le 24 septembre à 9h00, amphithéâtre du CEREGE, technopole de l'Arbois

Abstract : Age-related macular degeneration (AMD), manifested by the appearance of a dark spot in the center of the vision, has become a significant public health issue, with the number of patients set to rise over the coming decades. Since 2006, the pharmaceutical industry has introduced therapies with monthly intravitreal injections of anti-VEGF (vascular endothelial growth factor) antibodies to mitigate its development. Designing an intravitreal implant with antibody release controlled over twelve weeks has been proposed to simplify therapy management. Antibodies are thermally, chemically, and biologically sensitive therapeutic proteins. This study demonstrates the potential of the Sequential Dispersion Particles from Gas Saturated Solution (SD-PGSS) process for encapsulating sensitive active ingredients. The SD-PGSS process enables work to be carried out at moderate temperatures (38 °C) and without solvent. The study focused on the optimization of operating conditions through the investigation of polyesters (Polycaprolactone PCL, poly(Lactide-co-Glycolide) PLGA, and a polyether (Poly(Ethylene Glycol) PEG) biocompatible in the presence of supercritical CO2. Two operating conditions were selected: 38 °C/25 MPa for PCL and the PCL/PLGA blend (1:1 w/w) and 45 °C/25 MPa for PCL alone and the PCL/PEG blend (1:1 w/w). The implementation of the SD-PGSS process resulted in a repeatable process with high yields (80 - 95%). The study of two model molecules, lutein, a small hydrophobic molecule of therapeutic interest studied in an oral administration context, and bovine serum albumin, a hydrophilic protein studied in an intravitreal release scenario, demonstrated the repeatability of the process, the homogeneity of the final product, and the possibility of modulating the release in vitro. The antibody study demonstrated low activity maintenance and prolonged release for up to 8 weeks, leading to a prototype with compatible dimensions for ophthalmic use.

Jury
Géraldine PIEL                         Rapporteuse / Professeure, Université de Liège, Belgique
Ernesto DI MAIO                      Rapporteur / Professeur, Université de Naples-Federico II, Italie
Martial SAUCEAU                    Examinateur / Maître-assistant, Ecole des Mines d’Albi-Carmaux
John CONRATH                       Président du jury / Professeur - Chirurgien, Clinique Monticelli 
Elisabeth BADENS                   Directrice de thèse / Professeure, Aix-Marseille Université 
Yasmine MASMOUDI               Co-directrice de thèse / Maître de conférences , Aix-Marseille Université
Frédéric MATONTI                   Membre invité / Professeur - Chirurgien , Clinique Monticelli
Céline OLMIERE                      Membre invitée / Directrice scientifique, Théa Open Innovation